Your email has been successfully added to our mailing list.

×
0.00100140196274793 0.000200280392549672 0.000400560785099201 0.0101622271179652 0.00954936911676356 0.0190266372922091 0.00941317844982988 0.0226316843581014
Stock impact report

Can Akcea Therapeutics, Inc. and Ionis Pharmaceuticals, Inc. Recover? [The Motley Fool]

AKCEA THERAPEUTICS (AKCA) 
Last akcea therapeutics earnings: 2/25 04:05 pm Check Earnings Report
Company Research Source: The Motley Fool
A surprise rejection is a major setback for both partners, but not the end of the line. Akcea Therapeutics, Inc. ( NASDAQ:AKCA ) and  Ionis Pharmaceuticals, Inc.   ( NASDAQ:IONS ) recently announced a rejection that caught the market off guard. The companies didn't have much to say, but we can run down some clues that help explain the FDA's surprising decision. What happened?  The FDA issued the partners a complete response letter (CRL) regarding an application for a rare-disease drug called Waylivra, and they're being awfully tight-lipped about it. Even though these letters aren't subject to full disclosure, companies are usually quick to point out minor details that need to be addressed before submitting again.  Image source: Getty Images. Since Akcea and Ionis haven't offered any details, minor or otherwise, the problem probably won't be an easy fix. If I had to guess, I'd say the partners failed to satisfy safety concerns. During a study underpinnin Show less Read more
Impact Snapshot
Event Time:
AKCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AKCA alerts
Opt-in for
AKCA alerts

from News Quantified
Opt-in for
AKCA alerts

from News Quantified